NITRIC OXIDE SYNTHASES IN LUNG DEVELOPMENT AND BRONCHOPULMONARY DYSPLASIA
NITRIC OXIDE SYNTHASES IN LUNG DEVELOPMENT AND BRONCHOPULMONARY DYSPLASIA
批准号:
7562424
负责人:
PHILIP W SHAUL
金额:
$6.0万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-05-01 至 2008-04-30
关键词:
AnimalsAttenuatedBlood VesselsBreathingBronchopulmonary DysplasiaComputer Retrieval of Information on Scientific Projects DatabaseConditionDevelopmentDiseaseDown-RegulationExhalationFetal DevelopmentFetusFrozen SectionsFunctional disorderFundingGene ExpressionGrantGrowthHarvestHistologyHumanInflammatoryInstitutionKnowledgeLungMessenger RNAModelingNOS1 protein, humanNitric OxideNitric Oxide SynthaseNitric Oxide Synthase Type IPapioPerinatalPregnancyProductionProtein IsoformsProteinsResearchResearch PersonnelResourcesRoleSignaling MoleculeSourceStructureUnited States National Institutes of HealthWorkairway epitheliumcell typecytokinehuman NOS3 proteinindexinglaser capture microdissectionlung developmentmRNA Expressionnovelpostnatal
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The signaling molecule nitric oxide (NO) is critically involved in airway and vascular function in the developing lung. NO is produced by three isoforms of NO synthase (NOS), neuronal NOS (nNOS), endothelial NOS (eNOS), and inducible NOS (iNOS). Our preliminary work in normal baboon fetuses indicates that all three isoforms are expressed in airway epithelium, and that nNOS and eNOS are upregulated during late gestation to optimize No production in the perinatal period. Bronchopulmonary dysplasia (BPD) is an inflammatory condition which disrupts the development of the preterm human lung, and it is characterized by airway and pulmonary vascular dysfunction. Our initial studies in the baboon BPD model indicate that lung NO production and lung nNOS and eNOS expression are markedly attenuated during the genesis of BPD, and that NO replacement by inhalation (iNO) results in a sustained improvement in oxygenation index. The overall objective of this proposal is to investigate the role of alterations in NOS expression in the pathopysiology of BPD in the baboon model. The primary hypothesis is that pulmonary nNOS and eNOS expression are downregulated during the development of BPD, leading to diminished NO production and abnormal airway and vascular structure and function. The secondary hypothesis is that iNO reverses these abnormalities. Aim 1 is to define the normal ontogeny and changes in NOS protein and mRNA expression in early BPD, using approaches including laser capture microdissection to evaluate NOS mRNA levels in specific cell types harvested from frozen sections Aim 2 is to determine the role of each NOS isoform in airway and vascular function in studies of NOS antagonism in intact animals. Aim 3 is to reveal the changes in exhaled NO levels with fetal development and BPD, as well as the contribution of each NOS isoform to exhaled NO. Aim 4 is to determine the effects of iNO on airway and vascular function, on the pulmonary course of early BPD, and on lung histology. Aim 5 is to determine the mechanisms underlying constitutive nNOS and eNOS gene expression in cultured in baboon airway epithelium, and the role of cytokines in their downregulation. The results obtained will increase our knowledge of the role of NO in normally successful postnatal pulmonary adaptation and in the pathophysiology of BPD, thereby possibly leading to novel therapies for this devastating disorder.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Unraveling ApoE4 Promotion of Cardiometabolic Disease
-
批准号:10402846
-
项目类别:
-
资助金额:$57.04万
-
财政年份:2020
-
负责人:PHILIP W SHAUL
-
依托单位:
Unraveling ApoE4 Promotion of Cardiometabolic Disease
-
批准号:10620700
-
项目类别:
-
资助金额:$57.04万
-
财政年份:2020
-
负责人:PHILIP W SHAUL
-
依托单位:
Unraveling ApoE4 Promotion of Cardiometabolic Disease
-
批准号:10283188
-
项目类别:
-
资助金额:$34.87万
-
财政年份:2020
-
负责人:PHILIP W SHAUL
-
依托单位:
Unraveling ApoE4 Promotion of Cardiometabolic Disease
-
批准号:10192811
-
项目类别:
-
资助金额:$56.9万
-
财政年份:2020
-
负责人:PHILIP W SHAUL
-
依托单位:
Endothelial Estrogen Receptor Alpha and Cardiometabolic Disease
-
批准号:10394874
-
项目类别:
-
资助金额:$58.62万
-
财政年份:2019
-
负责人:PHILIP W SHAUL
-
依托单位:
Endothelial Estrogen Receptor Alpha and Cardiometabolic Disease
-
批准号:9816320
-
项目类别:
-
资助金额:$60.17万
-
财政年份:2019
-
负责人:PHILIP W SHAUL
-
依托单位:
Dichotomous Role of Endothelial SR-BI in Atherosclerosis
-
批准号:9235634
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2016
-
负责人:PHILIP W SHAUL
-
依托单位:
Fc gamma RIIB and Inflammation-Related Vascular Disease
-
批准号:8502166
-
项目类别:
-
资助金额:$35.63万
-
财政年份:2013
-
负责人:PHILIP W SHAUL
-
依托单位:
Training Program in Lung Biology and Disease
-
批准号:8607853
-
项目类别:
-
资助金额:$34.77万
-
财政年份:2009
-
负责人:PHILIP W SHAUL
-
依托单位:
Training Program in Lung Biology and Disease
-
批准号:9301617
-
项目类别:
-
资助金额:$36.59万
-
财政年份:2009
-
负责人:PHILIP W SHAUL
-
依托单位:
TRAINING PROGRAM IN LUNG BIOLOGY AND DISEASE
-
批准号:10621159
-
项目类别:
-
资助金额:$19.87万
-
财政年份:2009
-
负责人:PHILIP W SHAUL
-
依托单位:
TRAINING PROGRAM IN LUNG BIOLOGY AND DISEASE
-
批准号:10391485
-
项目类别:
-
资助金额:$33.01万
-
财政年份:2009
-
负责人:PHILIP W SHAUL
-
依托单位:
NITRIC OXIDE SYNTHASES IN LUNG DEVELOPMENT AND BRONCHOPULMONARY DYSPLASIA
-
批准号:7716052
-
项目类别:
-
资助金额:$2.26万
-
财政年份:2008
-
负责人:PHILIP W SHAUL
-
依托单位:
Oxysterols, Estrogen, Receptors Anatgonism and Vascular Disease
-
批准号:7269455
-
项目类别:
-
资助金额:$38.11万
-
财政年份:2006
-
负责人:PHILIP W SHAUL
-
依托单位:
NITRIC OXIDE SYNTHASES IN LUNG DEVELOPMENT AND BRONCHOPULMONARY DYSPLASIA
-
批准号:7349772
-
项目类别:
-
资助金额:$5.93万
-
财政年份:2006
-
负责人:PHILIP W SHAUL
-
依托单位:
Oxysterols, Estrogen Receptor Antagonism, and Vascular Disease
-
批准号:8466357
-
项目类别:
-
资助金额:$37.35万
-
财政年份:2006
-
负责人:PHILIP W SHAUL
-
依托单位:
Oxysterols, Estrogen Receptor Antagonism, and Vascular Disease
-
批准号:8269011
-
项目类别:
-
资助金额:$39.23万
-
财政年份:2006
-
负责人:PHILIP W SHAUL
-
依托单位:
Oxysterols, Estrogen, Receptors Anatgonism and Vascular Disease
-
批准号:7621022
-
项目类别:
-
资助金额:$38.11万
-
财政年份:2006
-
负责人:PHILIP W SHAUL
-
依托单位:
Oxysterols, Estrogen Receptor Antagonism, and Vascular Disease
-
批准号:7889197
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2006
-
负责人:PHILIP W SHAUL
-
依托单位:
Oxysterols, Estrogen, Receptors Anatgonism and Vascular Disease
-
批准号:7421066
-
项目类别:
-
资助金额:$38.11万
-
财政年份:2006
-
负责人:PHILIP W SHAUL
-
依托单位:
海外基金